Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Ningbo Li , Medicinal Chemistry , Shanxi Medical University, China

Dr. Ningbo Li is an accomplished Associate Professor at the School of Basic Medical Sciences, Shanxi Medical University, with a strong academic foundation and a passion for cancer research. With a doctorate in Organic Chemistry from Hunan University, Dr. Li has built a reputable career in green synthesis, targeted nano-drug delivery systems, and near-infrared fluorescent probes molecule for cancer diagnostics and therapy. He has led over 10 national and provincial research projects, published 46 SCI-indexed papers, and holds 5 authorized patents. Dr. Li also contributes to academia through textbooks and serves as a Young Editorial Board Member of Journal of Xiangtan University. His collaborations span leading institutions like Hunan University and Nankai University. With 863 citations and rising influence, Dr. Li is committed to pioneering innovative, low-toxicity cancer therapeutics and translating lab findings into clinical advances.

Professional Profile : 

Orcid   

Scopus 

Summary of Suitability for Award:

Dr. Ningbo Li, Associate Professor at Shanxi Medical University, has demonstrated exceptional research productivity and innovation in the fields of organic chemistry, nanomedicine, and cancer therapeutics. With over 50 SCI-indexed publications, 5 authorized patents, and leadership on more than 10 national and provincial-level research projects, Dr. Li has made significant contributions to targeted cancer treatment and green synthesis of anti-tumor agents. His pioneering work on magnetic nano-drug delivery systems and near-infrared fluorescent probes molecule showcases translational potential for clinical applications in oncology. Furthermore, his involvement in academic book publications, editorial duties, and inter-institutional collaborations reflects both leadership and scholarly impact. With a citation index of 863 and consistent innovation through funded research, Dr. Li exemplifies the qualities of a top-tier researcher. Dr. Ningbo Li is highly suitable for the “Best Researcher Award”, as he meets and exceeds the criteria in terms of research excellence, innovation, scientific impact, and societal relevance. His dedication to advancing cancer research through interdisciplinary chemistry and his strong track record in publications, patents, and funded projects make him a deserving and outstanding candidate for this prestigious recognition

🎓Education:

Dr. Ningbo Li’s academic journey began with a Bachelor’s degree in Chemistry from Shanxi Datong University (2005–2009). He pursued his postgraduate studies at Hunan University, earning a Master’s degree (2009–2012) and subsequently a Ph.D. in Organic Chemistry (2012–2015). His academic training emphasized organometallic chemistry, chiral complex synthesis, and catalysis, laying the groundwork for his future research in drug development and nanomedicine. During his doctoral studies, Dr. Li specialized in chiral Lewis acids, exploring their role in asymmetric synthesis—an area critical to pharmaceutical innovation. His graduate work was pivotal in shaping his later focus on bio-compatible metal complexes and tumor-targeted drug delivery platforms. The integration of organic synthesis with biomedical applications became a hallmark of his educational path, culminating in a multidisciplinary approach that bridges chemistry, nanotechnology, and medical science.

🏢Work Experience:

Dr. Ningbo Li began his academic career as a Lecturer (2015–2018) at the School of Basic Medical Sciences, Shanxi Medical University, where he conducted interdisciplinary research and mentored students. In December 2018, he was promoted to Associate Professor, reflecting his growing contributions to research and teaching. With over a decade in academia, he has supervised numerous graduate projects and continues to develop innovative strategies for targeted cancer therapy using nanomaterials and fluorescent probes. Dr. Li has consistently received competitive research funding from the National Natural Science Foundation of China and the Shanxi Provincial Science Foundations. He also actively contributes to national teaching excellence through authorship in leading organic chemistry textbooks. His dedication to both scientific advancement and student development underscores a career that blends high-impact research with academic leadership in medical and chemical sciences.

🏅Awards: 

While specific named awards are not detailed, Dr. Ningbo Li’s academic honors are evident through his prestigious research grants, editorial board appointment, and book contributions. He is the Principal Investigator for multiple national-level research projects, including NSFC Young Scholar Awards, which are highly competitive and indicative of early-career excellence. His appointment as a Young Editorial Board Member of the Journal of Xiangtan University (Natural Science Edition) further reflects his scientific influence and peer recognition. Dr. Li’s patents on chiral zirconium and titanium complexes also highlight his innovative contributions to chemical synthesis. Moreover, his extensive publishing record and the high citation index (863) attest to the impact of his research in organic and medicinal chemistry. Through his involvement in writing authoritative textbooks used in higher education, Dr. Li has contributed significantly to the academic development of students and educators in China.

🔬Research Focus:

Dr. Ningbo Li’s research is centered on the interdisciplinary interface of organic chemistry, nanotechnology, and cancer therapeutics, with a strong emphasis on green and sustainable chemistry. His primary focus lies in the design and synthesis of functionalized magnetic nanocomposites and near-infrared fluorescent probe molecules for the precise diagnosis and targeted treatment of malignant tumors. By engineering magnetic-targeted nano-drug delivery systems, his team aims to achieve site-specific drug accumulation, minimizing systemic toxicity and enhancing therapeutic efficacy. Another key area involves the green synthesis of novel bioactive compounds, particularly chiral organometallic complexes, which exhibit promising anti-tumor properties. His group also explores chiral Lewis acids as catalysts in asymmetric reactions, crucial for the development of structurally complex pharmaceuticals. Dr. Li’s research is highly translational, striving to bridge the gap between bench and bedside by accelerating the clinical application of biocompatible, efficient, and low-toxicity cancer therapeutics rooted in advanced chemical innovation.

Publication Top Notes:

1. g-C₃N₄-Based Heterogeneous Photocatalyzed Synthesis and Evaluation of Antitumor Activities of Fluoroalkylated 4H-Pyrido[1,2-a]pyrimidin-4-ones

2. Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells

3. GSH-Responsive Magnetic Mesoporous Silica Nanoparticles for Efficient Controlled Drug Delivery in Tumor Cells

 

​

Nagaprasad Puvvada | Nanomedicine | Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Nagaprasad Puvvada | Nanomedicine | Best Researcher Award

Associate Professor at VIT-AP University, India

Dr. Naga Prasad Puvvada is an accomplished researcher in the field of chemistry, specializing in nanotechnology and biomedical applications. He holds a Ph.D. from the Indian Institute of Technology, Kharagpur, and is currently an Associate Professor at VIT-AP University, Andhra Pradesh. His research focuses on the synthesis of nanomaterials for drug delivery, cancer therapeutics, and bioimaging, contributing significantly to advancements in biomedical sciences.

Author Metrics

Dr. Naga Prasad Puvvada has a significant academic footprint with a diverse range of publications. His works have been cited numerous times, contributing to an impressive H-index of 18 according to Web of Science. This reflects the impact and influence of his research in the field of chemistry, particularly in nanotechnology and biomedical applications.

Education

Dr. Puvvada earned his Ph.D. in Chemistry from the Indian Institute of Technology, Kharagpur in 2014. Prior to this, he completed his M.Sc. in Chemistry at the National Institute of Technology, Warangal, and his B.Sc. in Mathematics, Physics, and Chemistry from Hindu College, ANU University, Andhra Pradesh.

Research Focus

His research primarily focuses on nanotechnology and its applications in biomedical sciences. Dr. Puvvada specializes in the synthesis and characterization of nanomaterials for drug delivery, cancer therapeutics, and bioimaging. He is also involved in exploring the use of nanomaterials for neuroprotection and other biomedical applications.

Professional Journey

Dr. Puvvada’s professional journey includes diverse roles in academia and research. He is currently serving as an Associate Professor at VIT-AP University, Andhra Pradesh, where he continues to lead research initiatives in nanotechnology and chemistry. Previously, he held positions as an Assistant Professor at Indrashil University and as a DST Inspire Faculty at the Indian Institute of Chemical Technology, Hyderabad. He has also conducted postdoctoral research at Dalhousie Medicine New Brunswick, Canada.

Honors & Awards

Throughout his career, Dr. Puvvada has received several honors and awards for his contributions to science and research. These include the DST Inspire Faculty Award from the Government of India, the Telangana Academy Sciences-Young Scientist Award, and recognition for Best Oral Presentation by ACS Omega.

Publications Noted & Contributions

Dr. Puvvada has authored numerous publications in reputed journals, making significant contributions to the fields of nanotechnology, biochemistry, and materials science. His research spans topics such as the development of nanoparticles for targeted drug delivery, bioimaging using carbon dots, and nanocomposite materials for biomedical applications.

Title: Biocompatible fluorescent carbon nanoparticles as nanocarriers for targeted delivery of tamoxifen for regression of Breast carcinoma

  • Journal: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
  • Publication Date: November 2024
  • DOI: 10.1016/j.saa.2024.124721
  • Contributors: Nagaprasad Puvvada; Md. Abdus Salam Shaik; Dipanjan Samanta; Manisha Shaw; Imran Mondal; Rajarshi Basu; Angana Bhattacharya; Amita Pathak

Title: Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma

  • Journal: Nanomedicine
  • Publication Date: June 24, 2024
  • DOI: 10.1080/17435889.2024.2350357
  • Contributors: Gayathri Koula; Venu Yakati; Hari Krishnareddy Rachamalla; Keerti Bhamidipati; Muralidharan Kathirvel; Rajkumar Banerjee; Nagaprasad Puvvada

Title: Potential Benefits, Challenges and Perspectives of Various Methods and Materials Used for Hydrogen Storage

  • Journal: Energy & Fuels
  • Publication Date: February 15, 2024
  • DOI: 10.1021/acs.energyfuels.3c04084
  • Contributors: Pravas Kumar Panigrahi; Basavaiah Chandu; Mallikarjuna Rao Motapothula; Nagaprasad Puvvada

Title: Recent Advances in Nanostructured Materials for Application as Gas Sensors

  • Journal: ACS Omega
  • Publication Date: January 10, 2024
  • DOI: 10.1021/acsomega.3c06533
  • Contributors: Pravas Kumar Panigrahi; Basavaiah Chandu; Nagaprasad Puvvada

Title: Recent Advances in Chemically Engineered Nanostructures Impact on Ischemic Stroke Treatment

  • Journal: ACS Omega
  • Publication Date: December 5, 2023
  • DOI: 10.1021/acsomega.3c06228
  • Contributors: Gudivaka Sri Kanaka Durga Vijayalakshmi; Nagaprasad Puvvada

Research Timeline

His research timeline includes leading various projects focused on nanotechnology and biomedical applications. These projects have explored the use of nanoparticles for cancer therapy, neuroprotection, and biomedical diagnostics. Dr. Puvvada’s work also includes the development of novel nanomaterials and their applications in enhancing healthcare and medical treatments.

Collaborations and Projects

Dr. Puvvada has been actively involved in collaborative research initiatives both nationally and internationally. His collaborations have facilitated innovative research projects in nanotechnology and biomedical sciences, aiming to address critical healthcare challenges through advanced materials and technologies.

This summary provides a comprehensive overview of Dr. Naga Prasad Puvvada’s academic journey, research focus, and contributions to the field of chemistry and nanotechnology.